West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 362,300 | 173,800 | 661,800 | 514,100 | 338,500 |
| Depreciation Amortization | 59,700 | 29,600 | 122,300 | 87,900 | 57,900 |
| Income taxes - deferred | N/A | N/A | -42,900 | N/A | N/A |
| Accounts receivable | N/A | N/A | -123,500 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 16,800 | N/A | N/A |
| Other Working Capital | -98,500 | -50,200 | -198,100 | -206,000 | -168,500 |
| Other Operating Activity | 800 | -2,000 | 147,600 | 27,200 | 5,200 |
| Operating Cash Flow | $324,300 | $151,200 | $584,000 | $423,200 | $233,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -131,900 | -65,800 | -253,400 | -176,900 | -111,600 |
| Net Acquisitions | N/A | N/A | -2,200 | N/A | N/A |
| Other Investing Activity | -2,400 | -2,500 | 2,500 | 1,200 | 1,200 |
| Investing Cash Flow | $-134,300 | $-68,300 | $-253,100 | $-175,700 | $-110,400 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,100 | -600 | -2,200 | -1,100 | -1,100 |
| Common Stock Issued | 14,800 | 8,300 | 37,100 | 28,800 | 21,700 |
| Common Stock Repurchased | -194,800 | -165,900 | -151,900 | -151,800 | -151,500 |
| Dividend Paid | -26,500 | -13,400 | -51,100 | -37,800 | -25,200 |
| Other Financing Activity | -1,300 | -1,100 | 0 | 0 | 0 |
| Financing Cash Flow | $-208,900 | $-172,700 | $-168,100 | $-161,900 | $-156,100 |
| Exchange Rate Effect | -25,200 | -5,100 | -15,700 | -13,100 | -5,900 |
| Beginning Cash Position | 762,600 | 762,600 | 615,500 | 615,500 | 615,500 |
| End Cash Position | 718,500 | 667,700 | 762,600 | 688,000 | 576,200 |
| Net Cash Flow | $-44,100 | $-94,900 | $147,100 | $72,500 | $-39,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 324,300 | 151,200 | 584,000 | 423,200 | 233,100 |
| Capital Expenditure | -131,900 | -65,800 | -253,400 | -176,900 | -111,600 |
| Free Cash Flow | 192,400 | 85,400 | 330,600 | 246,300 | 121,500 |